January 26, 2015 11:28 PM ET

Capital Markets

Company Overview of BB Biotech Ventures III

Executive Profile

Jürg Eckhardt M.D.

Senior Investment Advisor Private Equity, BB Biotech Ventures III
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Jürg Eckhardt, M.D. is Senior Investment Advisor Private Equity at BB Biotech Ventures GP. Dr. Eckhardt is Partner of Bellevue Asset Management AG. He is a Partner at Bellevue Group in Kusnacht/Zurich, Switzerland, and responsible for venture capital investments. Dr. Eckhardt was employed at Global Life Science Ventures. While with Bellevue and previously while with Global Life Science Ventures, Dr. Eckhardt led several Biotech and Medtech investments in Europe and ...

Corporate Headquarters

Seestrasse 16
Zurich, -- CH-8700

Switzerland

Phone: 41 44 267 67 00
Fax: 41 44 267 67 01

Board Members Memberships

Former Director
Former Director
Former Director
Chairman of the Board
Director

Education

MBA
INSEAD
MD
Universität Basel

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BB Biotech Ventures III, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.